Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy
Key facts
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Sept 2024
- Expected to end
- Jan 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mechanical thrombectomy in proximal large vessels
- Rescue mechanical thrombectomy in distal vessels
- Record updated
- 29 April 2026
- Why it stopped
- Change for a phase II design
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- any patient with a large vessel occlusion in the M1 or M2 segment of the MCA (Middle Cerebral Artery), supraclinoid ICA (Internal Carotid Artery), or basilar artery who is a candidate for thrombectomy
- with a persistent distal occlusion in M2-M4, A1-A5, P1-P5 after successful recanalization of the proximal clot with mechanical thrombectomy and/or IV thrombolysis
Who cannot take part
- curative heparin or direct oral anticoagulants in previous 48 hours
- evidence of active bleeding on examination
- recent surgery with a significant risk of bleeding
- VKA (Vitamin K Antagonists) oral anticoagulation with INR (International Normalized Ratio) - > 1.7
- platelet count < 100 000/mm3
- poor 3 month prognosis from comorbidities
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In stroke patients, mechanical thrombectomy is now the standard of care when the stroke is due to large proximal cerebral vessel occlusion. The purpose of the 2BE3 trial is to test whether adjunct rescue treatment of persisting distal occlusions after successful proximal recanalization of the large vessel occlusion can be proposed as an additional intervention to restore reperfusion of affected stroke tissue and improve clinical outcomes.
Read full original descriptionShow less
The rescue therapies will be either mechanical (small stent retrievers and/or small aspiration catheters) or pharmacological (infusion of intra-arterial thrombolytics).
Patients will be randomized to conservative management (mechanical thrombectomy with or without IV thrombolytics of large proximal vessels) or rescue therapy (mechanical or pharmacological interventions in distal vessels in addition to conservative management). Each patient will be followed for 3 months post-intervention.
The data collected will be clinical assessments and angiographic imaging to evaluate the reperfusion state.
The 2 groups in the trial
- Conservative managementExisting treatment, for comparison
Mechanical thrombectomy of large vessel occlusions with or without administration of IV thrombolytics
Treatment: Mechanical thrombectomy in proximal large vessels
- Rescue therapyExisting treatment, for comparison
In addition to conservative management, rescue therapy in distal occlusions consisting of either mechanical thrombectomy with small stent retrievers with or without contact aspiration, or intra-arterial pharmacotherapy with tPA (tissue Plasminogen Activator), uPA (urokinase Plasminogen Activator) or tenecteplase.
Treatment: Mechanical thrombectomy in proximal large vessels and Rescue mechanical thrombectomy in distal vessels
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 April 2026